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Activation of heterodimeric E2F-DP transcription factors can drive the G1-S transition. Mutation of the
Drosophila melanogaster dE2F gene eliminates transcriptional activation of several replication factors at the
G1-S transition and compromises DNA replication. Here we describe a mutation in the Drosophila dDP gene.
As expected for a defect in the dE2F partner, this mutation blocks G1-S transcription of DmRNR2 and cyclin
E as previously described for mutations of dE2F. Mutation of dDP also causes an incomplete block of DNA
replication. When S phase is compromised by reducing the activity of dE2F-dDP by either a dE2F or dDP
mutation, the first phenotype detected is a reduction in the intensity of BrdU incorporation and a prolongation
of the labeling. Notably, in many cells, there was no detected delay in entry into this compromised S phase. In
contrast, when cyclin E function was reduced by a hypomorphic allele combination, BrdU incorporation was
robust but the timing of S-phase entry was delayed. We suggest that dE2F-dDP contributes to the expression
of two classes of gene products: replication factors, whose abundance has a graded effect on replication, and
cyclin E, which triggers an all-or-nothing transition from G1 to S phase.
One of the key points of cell cycle regulation is the transition
from G1 into S phase (50, 58). Despite the identification of a
number of the regulators that influence this transition, we do
not fully understand how it is controlled. Detailed analyses of
the phenotypes of mutations in the genes that regulate the
transition might provide more insight into the nature of the
decisive events that trigger the onset of DNA replication. Such
analyses of Saccharomyces cerevisiae have demonstrated two
types of phenotypes when entry into S phase is partially com-
promised (40, 55). Defects in some genes do not delay the
transition into S phase but prolong S phase, apparently by
reducing replication efficiency. Defects in other genes appear
to have an all-or-nothing effect on a decisive event that is
presumed to represent a switch from the G1 to the S-phase
states. Analysis of the behavior of cells in other organisms (26)
and of nuclei replicating in Xenopus laevis in vitro extracts (39)
suggests that an all-or-nothing switch is generally associated
with the G1-to-S transition.
Several findings argue for the importance of the activation of
transcription of specific genes that accompanies the G1-S tran-
sition. Chief among these is the finding that activation of spe-
cific transcription factors appears to occur immediately up-
stream of the decisive transition into S phase in yeast (1, 5),
Drosophila melanogaster (15, 17), and mammalian cells (37,
44). These factors stimulate a program of expression of genes
whose products are required for DNA replication. However,
because at least some of the required products are stable and
are present as a result of earlier expression, the activation of
this gene expression does not necessarily provide direct cou-
pling between replication factor transcription and entry into S
phase. The role of triggering entry into S phase may instead be
mediated by a second type of gene product induced as part of
the S-phase transcription program. In yeast (43, 45), Drosoph-
ila (16), and vertebrates (4, 23, 47), G1 cyclins are part of this
transcription program (e.g., CLN1 and CLN2 in S. cerevisiae
and cyclin E in metazoans). It is not entirely clear what roles
each of these two classes of induced gene products, replication
factors and G1 cyclins, plays in the G1-to-S transition.
In mammals and Drosophila, the G1-S-phase transcription
program is controlled by the E2F-DP family of heterodimeric
transcription factors (17, 37, 44, 59). Five related E2F genes
and two related DP genes have been identified in mammals
(59). Mice containing a homozygous knockout mutation of the
E2F-1 gene develop normally and are viable, indicating that
E2F-1 is not essential for cell cycle progression (22, 72). While
E2F-1 knockout mice do display several abnormal phenotypes,
most strikingly the eventual acquisition of a variety of tumors
in older individuals, the absence of a more dramatic phenotype
due to loss of E2F-1 function could be explained by redundan-
cies among the five known E2Fs. In Drosophila, only a single
E2F gene (dE2F) and DP gene (dDP) have yet been reported
(18, 27, 48), although an E2F-related sequence has recently
been identified as an EST from a Drosophila embryonic cDNA
library (28). As in mice, therefore, there exists a potential for
functional redundancy among Drosophila E2F genes. Never-
theless, mutations of dE2F cause lethality (6, 17). In embryos,
dE2F mutations block the activation of transcription that usu-
ally occurs at the G1-to-S transition and inhibit DNA replica-
tion (17). Thus, dE2F plays an essential role, likely as a re-
quirement for normal cell cycle progression.
Here we explore further the role of the activation of G1-S
phase transcription by identifying mutations of the dDP gene
and comparing embryonic phenotypes caused by genetic re-
ductions in the function of dDP, dE2F, or cyclin E, a down-
stream target of dE2F-dDP that is required for S phase (16, 33,
51). We find that both dDP and dE2F are required for the
activation of transcription of the same genes at the G1-to-S
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transition, consistent with dE2F and dDP acting as a het-
erodimer in vivo. If cyclin E and dE2F-dDP are jointly re-
quired to trigger a common step needed for the initiation of
DNA replication, then reductions in the functions of these
gene products should lead to similar phenotypes. In contrast to
this, we find distinct behaviors. Reducing dE2F-dDP function
first diminishes the rate of DNA replication, and only with
more severe reductions in functions do we detect delays or
defects in the transition into S phase. Reduction of cyclin E
function leads to a stochastic increase in the length of G1
without compromising replication in those cells that initiate
DNA synthesis. We discuss these results in terms of two dis-
tinct roles for dE2F-dDP and cyclin E in the pulse of transcrip-
tion at the G1-to-S transition: one role is a direct and dose-
dependent participation in DNA replication and the other is a
regulatory role that triggers an all-or-nothing change required
for S phase.
MATERIALS AND METHODS
Genetics and fly stocks. The overlapping Df(2R)vg56 and Df(2R)vg33 deficien-
cies (breakpoints 49D;49F and 49D;50A, respectively) and the recessive-lethal
EMS-induced mutations from the 49F region were isolated in a previously
described mutagenesis screen (36). Single mutant stocks representing a subset of
the 18 complementation groups were screened with the DmRNR2 probe (vr-3, -4,
-6, -8, -9, -10, -11, -13, -15, -17, -18, and -19). These were graciously provided to
us by Ting Wu of Harvard University. The dDPvr10 mutation we refer to through-
out the text was originally designated vr10-13 (36) and contained the recessive
markers al, b, c, and sp. We separated three other lethal mutations from the
original dDPvr10 chromosome by two successive meiotic recombinations with a
wild-type Sevelen second chromosome. The possibility that this new recombinant
chromosome (designated dDPvr10-5D) only contains the dDPvr10 semilethal allele
is supported by the rare (,2%) appearance of dDPvr10/dDPvr10 homozygous flies
in the stock. The presence of these three additional lethal mutations did not
significantly affect the phenotype in comparisons of DmRNR2 staining of
dDPvr10/dDPvr10, dDPvr10/Df(2R)vg56, dDPvr10-5D/dDPvr10-5D, and dDPvr10-5D/
Df(2R)vg56 mutant embryos. The cyclin EP28 and cyclin E05206 alleles are de-
scribed in references 2 and 32 and 33, respectively. The dE2F164 P-element allele
is described in reference 56; all other dE2F alleles are described in reference 17.
All second chromosome mutant stocks were maintained with a CyO P[w1;
wg-lacZ] balancer, allowing unambiguous identification of mutant progeny em-
bryos, which fail to express lacZ.
Molecular analysis of the dDP locus and dDP cDNA. Polytene chromosome
hybridizations were performed with digoxigenin-labeled dDP cDNA (encoding
amino acids 76 to 322) exactly as described previously (15). To identify the
dDPvr10 mutation, dDP genomic DNA was PCR amplified in three overlapping
regions with primers designed from the sequence of the full-length cDNA (see
below). Template DNA was prepared from single adult dDPvr10/Df(2R)vg56 or
Canton S control flies as described previously (25). For each genotype, products
from two independent PCR amplifications with Thermococcus litoralis DNA
polymerase (New England Biolabs) were subcloned into pBluescript and se-
quenced. The missense mutation was found in both dDPvr10 PCR amplifications
but not in the wild-type amplifications. Several pieces of evidence suggested that
our original dDP cDNA (18) was not full length. First, immunoblot analysis
revealed that heat shock expression of this cDNA produces a polypeptide that by
sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis migrates with
an apparent molecular mass ;8 kDa smaller than that of the endogenous dDP
(14). Second, Hao et al. (27) reported the amino acid sequence of a Drosophila
dDP cDNA that was nearly identical to the previously reported dDP cDNA
translation product (18) from residues 8 to 377 but contained an amino-terminal
extension of 74 amino acids. Third, the Dynlacht et al. (18) sequence does not
contain an in-frame stop codon upstream of the assigned initiator Met. We PCR
amplified the 59 region from a probable full-length dDP cDNA with nested
primers and template DNA prepared from a 0- to 4-h embryonic cDNA library
(7). In the first PCR, a vector primer that hybridizes 59 to the cloning site and
contains a HindIII recognition sequence was paired with a primer (59 ACAGT
TGTTGTCGTACGCAT) that hybridizes at the unique BsiWI site in the dDP
cDNA. A 1:1,000 dilution of the first reaction mixture was used as the template
in a second PCR that paired the same 59 vector primer with a dDP primer (59
TTGCCCGATGCCGCTAGCAC) that hybridizes at the unique NheI site just
upstream of the initiator Met assigned by Dynlacht et al. (18). The single product
from this reaction was cut with HindIII/NheI and subcloned in frame with the
Dynlacht et al. (18) cDNA contained in pBluescript SK.
Embryo in situ hybridization and BrdU labeling. Digoxigenin-labeled RNA
probes from DmRNR2 genomic DNA (15) and cyclin E type I cDNA (51) were
used for embryo in situ hybridizations as described previously (15, 38, 65).
Embryos were pulse labeled for 15 min in Schneider’s medium containing 1 mg
of BrdU/ml as described previously (19, 54). Incorporated BrdU was detected
with anti-BrdU mouse monoclonal primary antibody (Becton Dickinson) and
rhodamine-conjugated goat anti-mouse secondary antibody (Jackson). For heat
shock experiments, eggs from dDPvr10/CyO P[w1; wg-lacZ]; hsp70-dDP/hsp70-
dDP flies were collected on grape juice agar plates, aged at 18°C, and heat
shocked by floating the collection plate on the surface of a 37°C water bath for
30 min. After a 70-min recovery at room temperature, the embryos were fixed
and stained for DmRNR2 expression. The hsp70-dDP P-element construct is
described in reference 14.
Immunoblot analysis. Eggs were collected for 1 h at room temperature from
w; Df(2R)vg56/CyO P[w1; wg-lacZ] flies and aged 23 h at 17°C. The eggs were
dechorionated in 2.5% sodium hypochlorite, and the embryos were devitellinized
and fixed by shaking in a 1:1 mixture of methanol and heptane. The embryos
were washed twice with MeOH, transferred to an aqueous buffer containing
protease inhibitors (10 mM Tris [pH 7.8], 150 mM NaCl, 1 mM EDTA, 1 mM
phenylmethylsulfonyl fluoride, 2 mM benzamidine, 0.05% Tween 20), and
stained with the DNA binding dye Hoechst 33258. Ten Df(2R)vg56/Df(2R)vg56 or
10 Df(2R)vg56/CyO P[w1; wg-lacZ] methanol-fixed embryos were hand selected
under UV light with a fluorescence microscope. The three types of progeny from
this stock {Df(2R)vg56/Df(2R)vg56, Df(2R)vg56/CyO P[w1; wg-lacZ], and CyO
P[w1; wg-lacZ]/CyO P[w1; wg-lacZ]} could easily be distinguished from each
other at germ band-retracted stages due to differences between the aberrant
morphology of the deficiency homozygotes and the CyO/CyO balancer homozy-
gotes, which have a wg mutant phenotype. Selected embryos were dissociated by
boiling them for 3 min in sample buffer (62.5 mM Tris [pH 6.8], 2% SDS, 5%
glycerol, 5% b-mercaptoethanol) and subjected to SDS-polyacrylamide gel elec-
trophoresis. Separated proteins were electrophoretically transferred to nitrocel-
lulose, and dDP polypeptides were detected with a 1:10 dilution of monoclonal
antibody supernatant Yun1 (13).
Nucleotide sequence accession number. The additional dDP cDNA sequence
discussed above has been submitted to GenBank (accession no. AF031700).
RESULTS
Identification of a dDP mutation. Drosophila dDP cDNA
was cloned previously and shown to encode a functional bind-
ing partner for dE2F (18, 27). We took a reverse genetic
approach to identify mutations of dDP in order to test its role
in transcription and cell cycle control. Hybridizations of a dDP
cDNA probe to salivary gland polytene chromosomes (Fig.
1A) allowed us to map the dDP locus to position 49F on the
right arm of the second chromosome (not shown). A series of
overlapping deletion mutations that uncover region 49F were
generated by Lasko and Pardue (36). In situ analysis of
Df(2R)/1 polytene chromosomes revealed that the Df(2R)vg56
deletion chromosome failed to hybridize with our dDP cDNA
probe (Fig. 1A). We conclude from this result that dDP coding
sequences are missing in the Df(2R)vg56 deletion. Hao et al.
previously reported that dDP mapped outside this particular
deficiency (27). While we cannot readily explain this discrep-
ancy, two other observations confirm our mapping of dDP
within the Df(2R)vg56 deletion. First, in embryos that had pro-
gressed to cellularization or beyond, in situ hybridization de-
tected zygotic dDP expression in control but not in Df(2R)vg56/
Df(2R)vg56 embryos, consistent with the elimination of
maternal dDP RNA by cell cycle 14 (data not shown). Second,
Western blotting (see Materials and Methods) of total protein
extracted from germ band-retracted Df(2R)vg56/Df(2R)vg56
embryos with anti-dDP monoclonal antibodies indicated a se-
vere reduction in the amount of dDP protein compared to that
of Df(2R)vg56/1 sibling embryos (Fig. 1B). Taken together
these data indicate that the Df(2R)vg56 chromosome lacks a
functional dDP gene.
Mutations of dE2F reduce the zygotic expression of several
genes involved in DNA replication, including those encoding
the small subunit of ribonucleotide reductase (DmRNR2) and
PCNA (17). This phenotype is first apparent in the central
nervous system (CNS) of germ band-extended embryos during
late stage 11. In germ band-extended Df(2R)vg56/Df(2R)vg56
embryos the amount of DmRNR2 and PCNA mRNA in the
CNS was significantly reduced relative to that of the wild type
(Fig. 1C). An essentially identical gene expression defect was
observed in embryos homozygous for Df(2R)vg33 (not shown),
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another deletion mutation isolated by Lasko and Pardue that
removes polytene region 49F (36). Therefore, loss of the dDP
locus is associated with a phenotype that closely resembles the
phenotype associated with the loss of dE2F function.
Embryos homozygous for the Df(2R)vg56 and Df(2R)vg33
deletions deviate dramatically from wild-type morphology dur-
ing and after germ band retraction, presumably because of the
loss of multiple gene functions. This precluded an accurate
analysis of gene expression patterns in the deficiencies at stages
when we usually analyze the G1-S transcription program in
wild-type embryos. We therefore examined existing mutations
that mapped to 49F for perturbations in embryonic DmRNR2
expression. Mutations causing defective DmRNR2 expression
would be candidates for alleles of dDP. This approach had
proven successful in identifying dE2F mutations (17). A col-
lection of EMS-induced mutations representing 18 lethal
complementation groups that fail to complement Df(2R)vg56,
Df(2R)vg33, and other deletions in the 49F region were gener-
ated by Lasko and Pardue (36). Embryos were collected from
extant stocks carrying representative alleles from most of these
complementation groups (see Materials and Methods) and
probed for DmRNR2 expression by in situ hybridization. In one
lethal complementation group, designated dDPvr10, DmRNR2
expression was greatly reduced compared to that of wild-type
embryos (for germ band-retracted stages, cf. Fig. 2A and B).
No obvious change in the expression of DmRNR2 was observed
in any of the other mutants tested. At germ band-extended
stages, the dDPvr10 DmRNR2 expression phenotype was similar
to that caused by Df(2R)vg56 and Df(2R)vg33 (not shown),
suggesting that the dDPvr10 chromosome contained a mutation
in the relevant gene deleted in these deficiencies.
The original complementation mapping by Lasko and Par-
due (36) placed the dDPvr10 lethal mutation outside of the
Df(2R)vg56 deletion; i.e., dDPvr10 and Df(2R)vg56 were scored
FIG. 1. Identification of dDP mutations. (A) Hybridization of a Df(2R)vg56/1
salivary gland polytene chromosome with a dDP cDNA probe. The hybridization
signal (arrow) is lost in the Df(2R)vg56 deletion and consequently appears over
half the width of the heterozygous polytene chromosome. (B) Western blot of
extract of germ band-retracted embryos collected from the Df(2R)vg56/CyO stock
probed with anti-dDP monoclonal antibody. Since Df(2R)vg56 deletes the dDP
gene, any dDP protein present in Df(2R)vg56/Df(2R)vg56 embryos must be of
maternal origin. (C) Germ band-extended control (1/?) and Df(2R)vg56/
Df(2R)vg56 mutant stage 11 embryos subjected to in situ hybridization with a
digoxigenin-labeled probe derived from the DmRNR2 gene. DmRNR2 expres-
sion is failing in the developing ventral (toward the bottom) nerve cord of the
mutant embryo. (D) Intron and exon structure of the transcribed region of the
dDP gene. Exons are represented by shaded boxes, and introns are represented
by a straight line. ATG and TGA indicate the beginning and end of the dDP open
reading frame, respectively. The Arg-to-His missense mutation in exon 5 of the
dDPvr10 allele is indicated. (E) Alignment of a highly conserved region of the
heterodimerization domain of DPs from Drosophila (this paper), human (hum)
(30, 70), mouse (mus) (30, 49), and Xenopus (xen) (24). The numbers indicate
the position in each primary amino acid sequence. The position of the Arg-to-His
change in the dDPvr10 allele is indicated at the top.
FIG. 2. dDP is required for expression of DmRNR2. Each panel shows a
stage 13 embryo (anterior at the left and dorsal at the top) subjected to in situ
hybridization with a digoxigenin-labeled probe derived from the DmRNR2 gene.
(A) Wild type (WT). The pattern of DmRNR2 expression is coincident with the
pattern of DNA replication (Fig. 5A). This includes internal endoreduplicating
cells (e.g., midgut cells) and proliferating cells in the CNS. (B) dDPvr10/dDPvr10
(dDP2). DmRNR2 expression is not activated in the dDP mutant. (C) A dDPvr10/
dDPvr10; hsp70-dDP/hsp70-dDP (dDP2 hs-dDP) embryo subjected to a 30-min
37°C heat shock followed by a 70-min recovery at room temperature. Expression
of dDP cDNA in the mutant restores the normal pattern of DmRNR2 expression.
Each of the images has an internal focal plane in order to observe the anterior
midgut (arrows).
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as complementing mutations in their test crosses. Since this
was inconsistent with our interpretation of the DmRNR2 ex-
pression phenotype, we repeated the complementation tests
with our dDPvr10 stock (Table 1). When crosses with Df(2R)
vg56 flies were reared at 25°C, less than 2% of the adult prog-
eny (n 5 683) were of the dDPvr10/Df(2R)vg56 class (comple-
menting mutations should comprise 33% of adult progeny).
Similarly, in crosses with Df(2R)vg33 flies less than 1% of the
adult progeny (n 5 531) were of the dDPvr10/Df(2R)vg33 class.
These rare “escapers” were not phenotypically normal: many
flies had notched wings, some had rough eyes, and both males
and females were sterile (the females failed to lay eggs). Thus,
the dDPvr10 chromosome is semilethal at 25°C over both defi-
ciencies. Because this semilethality gives occasional survivors,
it could be scored as complementation when smaller numbers
of progeny are scored: presumably this explains the mapping
results of Lasko and Pardue. When we reared our crosses at
29°C, no Df(2R)/dDPvr10 flies eclosed (Table 1). A single copy
of a hsp70-dDP construct contained in a P-element vector was
sufficient to induce dDPvr10/Df(2R)vg56 or dDPvr10/Df(2R)vg33
flies to eclose at 29°C in the absence of a 37°C heat shock
treatment (Table 1). We conclude that the dDPvr10 mutation
fails to complement deficiencies that delete the dDP locus and
that low-level expression of a dDP cDNA can rescue dDPvr10/
Df(2R) lethality. Additionally, the incomplete lethality of the
dDPvr10/Df(2R) heteroallelic combination at lower tempera-
tures indicates either that dDP is not absolutely essential or
that dDPvr10 is not null for the locus.
These data suggested that the dDPvr10 chromosome con-
tained a mutation in the dDP gene. To confirm this, we mo-
lecularly characterized the dDP locus of wild-type and dDPvr10
chromosomes. The full-length dDP transcription unit spans
approximately 4 kb of genomic DNA and contains eight in-
trons (Fig. 1D). Our analysis predicts that the wild-type dDP
translation product consists of 446 residues with a predicted
molecular mass of 49,718 Da. This is in contrast to previously
published reports (see Materials and Methods). Southern blot-
ting indicated that there was no gross rearrangement of the
dDP locus in the dDPvr10 chromosome (data not shown). PCR
amplification and sequencing of the dDP locus from individual
dDPvr10/Df(2R)vg56 or dDPvr10/dDPvr10 adult flies revealed a
single nucleotide change encoding an Arg-to-His substitution
at residue 217 (Fig. 1E). This nucleotide change destroys a
unique AatII restriction site present in our dDP cDNA. This
consequently provided a means of readily assessing whether
the change is simply a wild-type polymorphism. PCR amplifi-
cation products of dDP genomic DNA isolated from dDPvr10/
CyO flies could be partially digested by AatII, indicating that
the CyO balancer chromosome contains the AatII site (not
shown). In contrast, similar dDP genomic PCR products de-
rived from a stock (vr18/CyO) containing a mutant chromo-
some (vr18) independently isolated in the original Lasko and
Pardue (36) mutagenesis screen could be completely digested
by AatII, strongly suggesting that the vr18 chromosome con-
tains the AatII site (not shown). Furthermore, vr18 comple-
ments dDPvr10 and does not cause defects in DmRNR2 expres-
sion (not shown). We conclude from this data that the Arg-to-
His amino acid change present in dDPvr10 is not a
polymorphism that was present in the flies originally mu-
tagenized by Lasko and Pardue (36).
Arg 217 is in a region of the dDP protein that is highly
conserved among Xenopus, mouse, human, and Drosophila
DPs (Fig. 1E). This region of mammalian DP-1 has been
shown to be required for dimerization with E2F-1 (3, 30, 34,
69). Thus, the Arg-to-His mutation may reduce the ability of
the dDPvr10 polypeptide to bind to dE2F. Dimerization of dDP
with dE2F is required for efficient DNA binding activity in
vitro (18). Moreover, coexpression of dDP and dE2F is needed
for effective transactivation of promoters containing dE2F-
dDP binding sites in cultured cells (13, 18) and for stimulating
transcription of endogenous target genes in embryos (14). We
conclude that the dDPvr10 chromosome contains an alteration
of the dDP gene and suggest that this change impairs the ability
of dDP protein to act as a transcription factor, perhaps due to
a reduced capacity to dimerize with dE2F. Royzman et al. (52)
have also recently reported the characterization of a dDP mu-
tant allele (a1) encoding an Arg-to-Cys change at residue 217.
Since dDPvr10 encodes a point mutation of dDP, we cannot
be sure that the phenotypes we describe below represent the
null situation. Moreover, we could still detect a small amount
of maternal dDP protein in germ band-retracted Df(2R)vg56/
Df(2R)vg56 embryos (Fig. 1B). Nevertheless, we did not ob-
serve obvious differences in the transcription and DNA repli-
cation phenotypes in dDPvr10/dDPvr10 and dDPvr10/Df(2R)vg56
embryos. This indicates that a twofold reduction in the zygotic
dose of dDPvr10 does not detectably enhance the phenotypes
we are scoring and suggests that dDPvr10 retains very little
function.
dDP is required for the expression of replication genes at
the G1-S transition. The first 16 cell cycles of Drosophila em-
bryogenesis lack a G1 phase. Following the introduction of a
G1 phase in cell cycle 17, subsequent entry into S phase is
accompanied by coordinate dE2F-dependent transcriptional
activation of replication factor genes (15). We used probes
derived from DmRNR2 or cyclin E as representatives of this
group of genes (cf. Fig. 2A and 4A). DmRNR2 transcripts are
present continuously and nearly uniformly prior to cycle 17 in
dDPvr10 mutants, as they are in the wild type (not shown). By
cycle 17, DmRNR2 is not expressed in its usual stereotypic
pattern in endoreduplicating tissues in the mutants (cf. Fig. 2A
and B). The dDPvr10 mutation also dramatically reduces
DmRNR2 expression in proliferating cells of the developing
CNS (brain lobes and ventral nerve cord). Heat shock expres-
sion of a dDP cDNA contained in a P-element transgene re-
stored the wild-type pattern of DmRNR2 expression (Fig. 2C).
We conclude that dDP function is required for the activation of
TABLE 1. Results of Df(2R)/dDPvr10 complementation tests
Cross
No. of adult progeny when reared ata:
25°C 29°C
Df(2R)vg56/CyO wg-lacZ 3 dDPvr10/CyO wg-lacZ 12/683 (2%) 0/487 (0%)
Df(2R)vg56/CyO wg-lacZ 3 dDPvr10/CyO wg-lacZ; hsp70-dDP/hsp70-dDP 20/265 (8%) 46/475 (10%)
Df(2R)vg33/CyO wg-lacZ 3 dDPvr10/CyO wg-lacZ 5/531 (1%) 0/467 (0%)
Df(2R)vg33/CyO wg-lacZ 3 dDPvr10/CyO wg-lacZ; hsp70-dDP/hsp70-dDP 21/388 (5%) 43/468 (9%)
a Data are expressed as the number of Df(2R)/dDPvr10 adult progeny/total number of adult progeny. Full complementation is 33% (CyO wg-lacZ/CyO wg-lacZ
progeny do not survive until adulthood).
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DmRNR2 transcription in both endoreduplicating and prolif-
erating cells.
The pattern of cyclin E expression resembles that of genes
encoding other replication factors during cycle 17 (16, 33).
However, while genes encoding other factors (e.g., DmRNR2)
require dE2F function in all domains of their expression (16),
cyclin E expression relies on dE2F in all domains except the
CNS (16). Similarly, expression of cyclin E relies on dDP in all
domains but the CNS (cf. Fig. 3A and B). The factors that
control cyclin E expression in the CNS have not yet been
identified.
Our results indicate that the dDP mutant phenotype is very
similar to that of dE2F mutants with respect to activation of
transcription of DmRNR2 and cyclin E. This is consistent with
a requirement for dE2F-dDP heterodimers in the transcription
of replication genes in vivo. However, if dE2F and dDP per-
form any functions independent of each other, then we would
also expect to observe differences in their respective pheno-
types. This possibility is further suggested by the presence of at
least one other E2F-like gene, and therefore at least one other
potential dDP binding partner, in Drosophila (28). We de-
tected a phenotypic difference in the embryonic CNS with a
probe derived from the Drosophila dMCM3 gene (22a, 64).
dMCM3 is a member of the MCM family of proteins, which act
at origins of replication and are required for S phase (8, 61,
67). dMCM genes are expressed in replicating cells in a pattern
similar to that of genes like DmRNR2 (21, 66). In dE2F mutant
embryos, there is substantially less dMCM3 RNA in the CNS
than in the wild-type CNS, indicating that dE2F is required for
dMCM3 expression in this tissue (cf. Fig. 4A and C). The
dDPvr10 mutation also alters dMCM3 expression, but in very
different way. The intense staining of particular cells seen in
wild-type embryos is absent in the mutant, suggesting that this
high-level expression requires dDP (Fig. 4B). However, other
cells of the CNS that normally have extremely low levels of
dMCM3 RNA exhibit increased staining (Fig. 4B). This dere-
pression of dMCM3 as a result of mutation of dDP suggests
that dDP normally plays a role in the repression of this gene,
at least in some cells of the CNS.
Mutation of dDP attenuates DNA replication and lengthens
S phase. Replicating nuclei can be readily observed in situ by
pulse labeling live embryos with BrdU and subsequently de-
tecting BrdU incorporation immunologically after fixation.
The wild-type profile of endocycle S phases during embryonic
stages 12 to 15 in the midgut has been well described (15, 60).
The first of these S phases begins from G1 of cycle 17 (Fig. 5A).
dDPvr10/dDPvr10 and dDPvr10/Df(2R)vg56 mutant embryos in-
corporated much less BrdU in the midgut during a 15-min
pulse labeling than did wild-type embryos (for dDPvr10/dDPvr10,
cf. Fig. 5A and B). Reduced BrdU incorporation is also seen in
FIG. 3. dDP is required for cyclin E expression at the G1-S transition in
endoreduplicating cells. Each panel shows a stage 13 embryo (anterior at the left
and dorsal at the top) subjected to in situ hybridization with a digoxigenin-
labeled probe derived from cyclin E cDNA. (A) Wild type (WT). The arrows
indicate the midgut. The arrowhead indicates the ventral nerve cord. (B)
dDPvr10/Df(2R)vg56 (dDP2). The cells of the midgut normally express cyclin E at
this stage but fail to do so in the dDP mutant. CNS expression of cyclin E is
normal in the dDP mutant. (C) cyclin E5206/cyclin E5206 mutant embryo. This
allele contains a P-element insertion into the upstream regulatory region of the
cyclin E gene (33). cyclin E is not expressed in the midgut or other cells that
normally endoreduplicate but is expressed in the CNS. (D) cyclin E5206/cyclin
EP28 transheterozygote. Expression of cyclin E, presumably from the cyclin EP28
homolog, initiates at the correct developmental time in the midgut. However,
transcription is not down regulated as usual, leading to persistently high levels of
cyclin E mRNA.
FIG. 4. Mutation of dDP and dE2F causes distinct phenotypes. Each panel
shows a stage 14 embryo (anterior at the left) subjected to in situ hybridization
with a digoxigenin-labeled probe derived from dMCM3 cDNA. The perspective
is ventral to view the nerve cord (VNC) of the CNS (arrowheads). (A) Wild type
(WT). Expression occurs coincident with replication, generating the observed
pattern. (B) dDPvr10/dDPvr10 mutant. dMCM3 expression continues in the VNC,
but occurs in an expanded domain of cells. This suggests that dDP functions to
prevent dMCM3 from becoming derepressed in this tissue. (C) dE2F91/dE2F91
null mutant. Very little if any dMCM3 expression can be detected in the VNC,
indicating that dE2F is required for normal dMCM3 expression. No ectopic
dMCM3 expression is observed, perhaps because dE2F does not perform an
essential repression function. Residual dMCM3 expression in the brain accounts
for the out-of-focus staining at the left.
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other endocycling tissues, such as the hindgut. This decrease in
BrdU incorporation was not restricted to endocycles, as mitotic
cells in the CNS also labeled poorly relative to the wild type (cf.
Fig. 5A and B). We conclude that dDP function is required for
wild-type levels of DNA synthesis in endocycling and dividing
cells.
Analysis of BrdU incorporation in an embryo allows one to
score the timing of entry into S phase and the duration of S
phase in addition to scoring the level of labeled nucleotide
incorporated during the pulse. As described above, the dDPvr10
mutant embryos exhibit an obvious reduction in BrdU incor-
poration, but the pattern of BrdU incorporation reveals that
the programming of the G1-to-S transition still operates. The
tissues that enter S phase 17 relatively early in the wild type,
such as the anterior midgut, posterior midgut, and hindgut,
appear to begin their compromised S phase at a similar em-
bryonic stage in the dDP mutant (Fig. 5B). This demonstrated
that reduction of dDP function first affects the level of incor-
poration rather than the timing of the transition from G1 to S
phase. Analysis of the incorporation pattern in successively
older embryos, whose age is determined both by time from egg
deposition and by staging according to morphological criteria,
defines the duration of S phase. Whereas the tissues that begin
S phase 17 early in wild-type embryos discontinue incorpora-
tion by stage 14, in the mutant incorporation continues at this
stage. This changes the pattern of BrdU incorporation such
that cells which no longer label in the wild type are still labeled
in the mutant (e.g., anterior midgut cells [Fig. 5D and E]). The
prolongation of S phase combined with decreased BrdU incor-
poration suggests that the replication rate is reduced. Since the
dDPvr10 mutant compromises the expression of genes such as
DmRNR2, we suggest that the mutant exhibits a reduction in
DNA synthesis as a result of decreases in the levels of repli-
cation functions.
Our original analysis of the replication phenotype in dE2F
mutant embryos led us to the conclusion that the mutation
blocked S phase (17), whereas the analysis of the dDP muta-
tion suggests a more quantitative defect. We thus conducted
more detailed analyses of dE2F mutants. The results suggest
that reductions in the function of dE2F also have a quantitative
effect on replication. dE2F164 is a homozygous, viable, hypo-
morphic P-element-induced allele of dE2F that expresses
nearly undetectable levels of dE2F mRNA (56). Nonetheless,
dE2F164 fully complements a deletion [Df(3R)eD7] of the dE2F
gene: adult flies are viable and fertile. Despite the absence of
an effect on viability, we detected a change in the pattern of
BrdU incorporation in Df(3R)eD7/dE2F164 mutant embryos. As
with the dDPvr10 mutant, this pattern is consistent with a pro-
longation of S phase 17 in the midgut (cf. Fig. 5E and 6A). This
suggests that the requirement for dE2F can be satisfied by
relatively low levels of activity and that a reduction in the
efficiency of S phase is not lethal. We therefore reexamined
embryos homozygous for lethal null alleles of dE2F. We could
detect a low level of BrdU incorporation in the midgut, as well
as in the CNS (Fig. 6B). This incorporation can be more
readily detected when longer BrdU-labeling periods are used
(e.g., 40 vs. 15 min). Again, the pattern of BrdU incorporation
was altered in a way that suggests the prolongation of S phase
17 in the midgut (cf. Fig. 5E and 6B). We conclude that
reductions in function of dE2F/dDP activity over a large range
result in a graded reduction in S phase.
FIG. 5. Different cell cycle roles for cyclin E and dDP. Embryos were collected and aged until stage 13 (A to C) or stage 14 (D to F), pulse labeled for 15 min with
BrdU, and then immediately fixed. BrdU that incorporated into replicating nuclei during the pulse was subsequently detected by indirect immunofluorescence. The
orientation of each embryo is the same as in Fig. 2. (A and D) Wild type (WT). (B and E) dDPvr10/dDPvr10 (dDP). (C and F) cyclin EP28/cyclin E05206 (cyc E). The arrows
indicate the cells of the anterior midgut (AMG). These cells begin S phase 17 during stage 12, continue replication into stage 13 (A), and exit S phase by stage 14 (D).
In the dDP mutant, all or most of the AMG cells enter S phase at the correct time but incorporate much less BrdU (B). By stage 14 these cells are still replicating (E),
indicating that S phase is longer than it is in the wild type. In the hypomorphic cyclin E mutant, the AMG cells do not begin S phase 17 on schedule (C) but eventually
enter S phase in a random fashion beginning in stage 14 (F). Thus, G1 of cycle 17 is longer than usual in these cells. The actual length of G1 depends upon when the
cells reach the critical level of cyclin E activity that triggers S phase. Also note that replication in the CNS appears normal, consistent with wild-type cyclin E expression
in the CNS of cyclin E05206 mutants.
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Cyclin E triggers S phase in an all-or-nothing manner. Dur-
ing G1 phase, eukaryotic cells are thought to respond to
growth-promoting signals by making a commitment to enter
the cell cycle and begin S phase. A typical feature of the
process of commitment is that it is an all-or-nothing step.
Reductions in function of a component contributing to such an
all-or-nothing step ought to exhibit a sharp threshold, with
reductions below a critical level blocking the ability to progress
beyond the decisive step. As described above, mutations that
compromise the activity of dE2F-dDP suggest that this tran-
scription factor makes a graded contribution to the efficiency
of S phase, the antithesis of the expectation for a regulator of
a decisive all-or-nothing transition.
Cyclin E mutations on the other hand show the behavior
expected for a contribution to an all-or-nothing transition.
Cyclin E null mutations complete embryonic cell cycle 16 and
cause an arrest in G1 of cell cycle 17 (33). Our immunofluo-
rescent methods cannot detect any BrdU incorporation in
these mutants. Thus, in this instance the cyclin E threshold is
never reached. To test the consequence to cell cycle progres-
sion of reduced but significant levels of cyclin E function, we
used two hypomorphic mutations of cyclin E: cyclin E05206, a
P-element insertion mutation that eliminates cyclin E expres-
sion in endocycling cells but not in the CNS (Fig. 3C), and
cyclin EP28, an EMS-induced mutation. We examined BrdU
incorporation in the anterior midgut cells of cyclin E05206/cyclin
EP28 transheterozygous mutant embryos. At stage 13, no BrdU
incorporation was detected (Fig. 5C). These cells are therefore
still in G1 of cycle 17 at a time when wild-type cells have
already begun S phase 17 (Fig. 5A). However, at stage 14 we
could detect BrdU incorporation in some of the anterior mid-
gut cells (Fig. 5F). The number of BrdU-positive cells varied
from embryo to embryo, and the distribution of cells within the
tissue was random. In sharp contrast to the results with the
dDP and dE2F mutations, the level of BrdU staining in those
nuclei that had made the transition to S phase was just as
intense as in the wild type. We interpret this phenotype as a
delay of the G1-S transition, or a reduction of the probability of
undergoing this transition, and suggest that it reflects a partial
defect in the execution of an all-or-nothing event leading to S
phase (Fig. 7).
Strikingly, a small number of cyclin E05206/cyclin EP28 prog-
eny eclosed as adult flies (12 out of 317 total progeny [3.7%]).
These flies were sterile, had rough eyes, and had incomplete
formation of the fifth wing vein. Therefore, this combination of
cyclin E alleles is semilethal. This result indicates that dramatic
alterations to the timing of the G1-S transition at embryonic
stages is still compatible with a substantial amount of devel-
opment.
Drosophila cyclin E inhibits its own expression in endocycles
by one or more negative feedback loops (16, 41, 53), and
mammalian cyclin E has been shown to promote its own de-
struction (9, 68). As a result, cyclin E is ordinarily expressed
only transiently at the G1-S transition. We examined the be-
havior of cyclin E expression in cyclin E05206/cyclin EP28 em-
bryos and found that these embryos activate cyclin E transcrip-
tion (presumably from the mutant cyclin EP28 chromosome) at
the correct time in cycle 17 in the midgut but fail to terminate
transcription at the normal time (Fig. 3D). This, and similar
results with cyclin E null mutants (16, 53), suggests that the
normal down regulation of cyclin E synthesis involves negative
feedback. There appear to be multiple components to this
negative feedback. Cyclin E acts particularly effectively as a
repressor of its own expression (53), and in a separate step it
plays a role in the down regulation of dE2F-dDP-dependent
transcription in general (16). This mode of regulation buffers
the effect of mutation on cyclin E function in that mutant
alleles of cyclin E are expressed for a longer time and mRNA
(and presumably the mutant protein it encodes) can accumu-
late to higher levels (Fig. 3D). Therefore, we propose that part
of the delay in progress to S phase in the cyclin E05206/cyclin
EP28 mutant is due to an extension in the time required for
mutant cyclin E protein to achieve a critical threshold of cyclin
E function (e.g., activating cdk2).
dE2F/dDP contributes to the all-or-nothing transition into S
phase. Based on the characteristic defects seen in hypomorphic
conditions for cyclin E and dE2F, and in the dDPvr10 mutant, it
appears that cyclin E has important inputs into an all-or-noth-
ing event required for transition to S phase while dE2F-dDP
makes a quantitative contribution to functions required for S
phase. However, our work has demonstrated that cyclin E
expression requires dE2F and dDP at the G1-S transition of
cycle 17. We consequently expected that dE2F-dDP should
also make a contribution to the G1-S phase trigger. Such a
contribution might be masked if a relatively high level of dE2F-
dDP activity were required to fully satisfy the quantitative
contribution to S phase while a very low level of activity of
dE2F-dDP provided sufficient cyclin E to satisfy the threshold
of the all-or-nothing event. Indeed, further characterization of
the dDP and dE2F mutant phenotypes suggests that this is the
case.
As we described above, cells that enter S phase 17 relatively
early (e.g., anterior midgut cells) in the wild type do so at
approximately the normal time in the dDPvr10 mutant. How-
ever, the ensuing S phase is prolonged in the mutant and
displays a reduced rate of BrdU incorporation. If a low level of
maternal dDP persists until the time that tissues begin to enter
S phase 17, one might expect that, as a result of continued
decay, cells which enter S phase early would benefit from a
higher level of this maternal dDP than cells which enter S
phase at a later stage. Consistent with this, S phase 18 in the
central midgut (Fig. 5D), which begins about 2 h after the
beginning of S phase 17 in the anterior midgut, seems to be
more dramatically affected in the dDPvr10 mutant embryos
(Fig. 5E). Importantly, the timing of entry into S phase 18 is
FIG. 6. Prolonged S phase in dE2F mutants. Stage 14 dE2F164/Def(3R)eD7
(hypo) (A) and dE2F7172/dE2F7172 (null) (B) embryos pulse labeled for 15 min
with BrdU. S phase 17 continues in the anterior midgut (arrows) when in the wild
type it has already finished (Fig. 5D). This is an indication that S phase is
prolonged in the mutants. In the central portion of the midgut (arrowheads) S
phase 18 has not started on schedule for most of the cells (Fig. 5D). This
indicates that dE2F also contributes to correct timing of the G1-S transition.
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affected as well as the efficiency of replication. In stage 14, only
a few cells in the mutant’s central midgut have begun to incor-
porate BrdU (Fig. 5E) compared to the number in wild-type
embryos (Fig. 5D). These cells have either been arrested or
they initiate S phase at a much later time than the wild type
(i.e., beyond the stages we have examined). Moreover, the few
cells that do incorporate BrdU are stained weakly, again con-
sistent with a reduced rate of DNA replication once S phase is
initiated. A very similar phenotype is seen in the same cells of
dE2F mutant embryos (Fig. 6). These data suggest that dE2F-
dDP contributes both to the correct timing of the G1-S tran-
sition and to the efficiency of S phase.
DISCUSSION
In this report we describe the identification and character-
ization of mutations of the Drosophila dDP gene, which en-
codes a component of the E2F-DP transcription factor. dDP is
required for activation of expression of replication genes at the
G1-S transition in embryonic cells, and mutants have an atten-
uated and sometimes delayed S phase. Characterization of
BrdU incorporation in different mutant backgrounds and at
different embryonic stages suggests that reductions in dE2F-
dDP over a large range results in graded attenuation of DNA
replication and that only severe reductions in dE2F-dDP func-
tion delay or block entry into S phase. In contrast, partial loss
of function of cyclin E results in a delay of S-phase entry
without detectable diminution of BrdU incorporation. We sug-
gest that dE2F-dDP makes two different kinds of contributions
to DNA replication. It drives the expression of numerous rep-
lication functions, some of which are limiting for the rate of
DNA replication. Additionally, it drives the expression of at
least one product, cyclin E, that is required to trigger an all-
or-nothing transition from G1 into S phase.
dE2F and dDP collaborate to activate G1-S transcription. A
substantial amount of biochemical evidence indicates that
E2F-DP heterodimers function as a DNA binding transcrip-
tion factor that contributes to the activation of transcription at
the G1-S transition (reviewed in references 37 and 59). Our
previous genetic analysis had demonstrated that the Drosophila
dE2F gene is essential for transcriptional activation of several
replication genes at the G1-S transition in embryos. The
present work demonstrates that mutation of the Drosophila
dDP gene also eliminates this activation of expression for the
DmRNR2 and cyclin E genes. While this article was undergoing
review, Royzman et al. reported similar transcriptional pheno-
types due to mutation of dDP (52). The parallel defects in the
transcription of several genes are consistent with the joint
action of dE2F and dDP in this aspect of their function. Sev-
eral experiments imply that transcriptional activation is likely a
result of a direct interaction between dE2F-dDP and cis-acting
elements in the promoters of replication genes. Expression of
the dE2F cDNA stimulates the DNA polymerase a promoter
in cultured Drosophila cells (48). Furthermore, dE2F-dDP
binding sites found upstream of the PCNA transcriptional start
site are required for reporter gene expression in cell culture
and b-galactosidase activity in embryo extracts prepared from
flies carrying PCNA-promoter-lacZ fusion transgenes (71).
Is normal regulation of S phase essential? The vr10 allele of
dDP produced some adult flies when it was heterozygous to a
FIG. 7. Model of dE2F-dDP and cyclin E function at the G1-S transition and schematic representation of the G1-S transition and BrdU incorporation in the
embryonic midgut. (A) Wild type. Components of the prereplicative complex (open symbols) assemble on chromosomes (parallel lines) at origins of DNA replication
(solid rectangles). Since E2F-DP is required for the transcription of genes encoding known components of prereplicative complexes like dMCM3 in Drosophila and
HsOrc1 in humans (46), we propose that dE2F-dDP contributes to prereplicative complex assembly. Cells remain in G1 until they are induced to progress through the
cell cycle by a developmental signal. DNA synthesis is then triggered at the beginning of S phase via cyclin E action, and bidirectional replication forks appear in the
chromosome (ovals). After BrdU pulse labeling and in situ immunofluorescent detection of incorporated BrdU, the nuclei in a field of cells that synchronously entered
S phase stain brightly and uniformly (nine open circles on the black background). (B) Reduced cyclin E function. Prereplicative complexes form normally at a frequency
identical to that of the wild type, because dE2F-dDP is activated independently of cyclin E (16). If cyclin E function is eliminated, replication is not triggered and cells
remain in G1. If the cyclin E function is reduced but not eliminated, S phase will still be triggered provided cyclin E function can eventually achieve the critical threshold.
In the latter situation, G1 is prolonged and DNA replication is normal once S phase begins. In a field of cells of this type, the length of G1 might vary stochastically
as cells approach the S phase threshold. The pattern of BrdU-labeled nuclei would appear random, and each nucleus would have the wild-type intensity of staining
(three open circles instead of nine on the black background). (C) Reduced dE2F-dDP function. Decreased provision of components causes limited assembly of
prereplicative complexes. If those that assemble are triggered at the usual time in development, the length of G1 does not change. However, fewer prereplicative
complexes initiate fewer bidirectional replication forks. Consequently, S phase is prolonged and BrdU incorporation during pulse labeling is significantly reduced. A
field of cells of this type appears uniformly and weakly labeled (nine shaded circles on the black background). (Note that the symbols designating components of the
prereplicative complex are not shown on the DNA after bidirectional DNA synthesis has begun for the purpose of clarity. Some components of this complex [e.g., ORC]
are thought to remain bound to the DNA throughout the entire cell cycle [11].)
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deficiency for the locus. While it is possible that this result is in
part due to residual function of this mutant allele, it is clear
that this same allele reduces G1-S transcription of various
replication genes to levels below detection and substantially
compromises replication in the embryonic S phases that we
have examined. Similarly, a dE2F hypomorphic allele that al-
ters embryonic S phases is viable, and a combination of cyclin
E alleles that greatly altered the embryonic S-phase program
(Fig. 5F) nonetheless gave viable flies. Based on these obser-
vations, we suggest that most aspects of patterning, growth,
and differentiation are regulated in ways that are not easily
disturbed by alterations in the G1-S program. Note that adult
dDPvr10 mutant flies were rare, defective, and infertile. Hence
the activity of the gene and presumably the control of S phase
is clearly of some relevance to development, but it is nonethe-
less surprising that an intact fly can be produced when defects
in S phase can be scored in midembryogenesis.
Is dE2F-dDP activity essential to S phase? We previously
reported that the compromised embryonic S phases in a dE2F
mutant indicated that dE2F function was required for the G1-S
transition (17). However, here we have shown that the avail-
able dE2F and dDP mutations have their primary effect on the
efficiency of S phase. If dE2F-dDP is an integral part of the
normal cascade of signaling that triggers S phase, we might
expect that the mutations would result in an absolute block to
S phase rather than a reduction in its efficiency. However, we
find that many cells enter a compromised S phase 17 according
to a normal schedule. Nonetheless, we cannot conclude that
dE2F-dDP function is dispensable for the G1-S transition, be-
cause it is possible that the threshold of dE2F-dDP activity
required to drive the transition is lower than the levels of
dE2F-dDP required for maximal efficiency of DNA replica-
tion.
There are three possible sources of dE2F-dDP activity in the
mutant embryos. First, it appears that a small amount of ma-
ternally expressed protein persists to late embryonic stages
(Fig. 1B). Second, the mutations might not remove all activity
of the gene. Third, there may be homologs that provide a
comparable activity. Indeed, sequences of random cDNAs
(ESTs) by the Berkeley Drosophila Genome Project uncovered
the existence of a second dE2F homolog (28). This and per-
haps other undetected homologs of dE2F and/or dDP might
contribute to dE2F-dDP activity in the mutant backgrounds.
Hence, while our experiments allow us to say that mutations
that reduce dE2F-dDP activity affect S phase, it is more diffi-
cult to address whether DNA replication seen in these mutant
backgrounds depends on a low level of residual dE2F-dDP
activity from one or more of these sources.
One important observation leads us to suggest that dE2F-
dDP contributes to the transition from G1 to S as well as to the
efficiency of DNA replication. Analysis of a later S phase (S
phase 18 in the central midgut), when maternal functions have
further decayed, shows that entry into S phase is delayed and
variable. Additionally, an involvement of dE2F-dDP in the
G1-S transition is also suggested by the involvement of the
dE2F-dDP-stimulated gene cyclin E in triggering the G1-S
transition (see below) and by the extraordinary correlation
between the schedule of activation of dE2F-dDP and the de-
velopmental program of S phases. We consequently favor the
interpretation that dE2F-dDP drives expression of cyclin E at
the G1-S transition and that cyclin E is essential for this tran-
sition.
Our favored interpretation might seem strained because it
requires that undetectable levels of cyclin E RNA trigger S
phase. However, the genetics indicates that zygotic expression
of cyclin E is absolutely required for S phase 17 (33). Hence,
regardless of our failure to detect cyclin E RNA in the dE2F
and dDP mutant embryos, sufficient cyclin E protein must
accumulate to allow S phase. How can undetectable levels of
cyclin E mRNA produce sufficient cyclin E protein to trigger S
phase? We suggest that particular aspects of cyclin E regula-
tion might allow gradual accumulation of cyclin E protein at
very low levels of mRNA. Cyclin E inhibits its own dE2F-dDP-
mediated transcription in embryos (16, 53). Moreover, mam-
malian cyclin E protein appears to drive its own destruction
through ubiquitin-mediated proteolysis (9, 68). Hence, once
expression begins cyclin E will accumulate until it reaches
levels that activate these negative feedback loops. As the level
of cyclin E RNA is reduced, the rate of accumulation of cyclin
E protein will decline, but it will accumulate over a longer
period and ultimately reach its threshold levels. Accordingly,
we suggest that severe reductions in dE2F-dDP activity would
be required before one could detect a substantial defect in the
G1-S transition. In addition, it is also possible that in the
complete absence of dE2F-dDP, low basal expression of cyclin
E might allow accumulation of cyclin E protein over a very long
time. In this case, entry into S phase would not be timed
properly, but could still occur. Such dE2F-dDP-independent
expression of cyclin E might sustain the growth of dE2F and
dDP mutant larvae, as reported by Royzman et al. (52).
The dE2F-dDP contribution to the efficiency of DNA repli-
cation. In S. cerevisiae, limitation of components that bind
replication origins (e.g., ORC and MCM proteins) causes a
reduced rate of replication that is associated with reduced
origin utilization (reviewed in reference 11). In Drosophila,
reduction in the function of dMCM2 results in a prolongation
of S phase consistent with such a reduction in origin firing (66).
We suggest an analogous interpretation of the phenotype
caused by reduction of dE2F-dDP function (Fig. 7). In both the
dDP and dE2F mutant embryos the first defect in DNA repli-
cation that appears is a reduction in the intensity of BrdU
incorporation. An increase in the length of S phase 17 ob-
served in the midgut argues that this decreased incorporation
is associated with a reduced rate of DNA replication. Although
we have not identified a specific factor whose expression is rate
limiting for these embryonic S phases, we have demonstrated
that dE2F and dDP are required for the expression of several
genes encoding replication factors. We propose that one or
more replication factors become limiting when dE2F-dDP
function is compromised and that the consequence is a reduc-
tion in the number of forks that successfully initiate replica-
tion.
Cyclin E provides an S-phase threshold. Evidence from
many different systems indicates that cyclin E-cdk2 activity is
required for cell cycle progression (reviewed in reference 29).
In what way is cyclin E-cdk2 activity required for S phase?
Here we have shown that Drosophila cyclin E provides a
threshold for entry into S phase. By reducing but not eliminat-
ing cyclin E function by a hypomorphic combination of alleles,
we showed that endoreduplicating embryonic midgut cells fail
to execute a developmentally controlled G1-S transition on
schedule in cell cycle 17. But rather than remaining in G1
arrest indefinitely, these cells subsequently enter S phase. In
this delayed S phase, BrdU incorporation appears normal,
probably because dE2F-dDP is independently activated in
these cells and the replication machinery other than cyclin E is
not limiting (17). The midgut cells do not all enter S phase at
the same time, however, but rather at random times. We in-
terpret this stochastic entry into S phase in cycle 17 as evidence
for the participation of cyclin E in a molecular threshold. That
is, when cyclin E, and by extension cyclin E-cdk2 activity,
reaches a critical level S phase is triggered in an all-or-nothing
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manner. This will only be true if cyclin E function can continue
to accumulate during the extended G1 period. Consistent with
this, the mutant cyclin E gene is activated at the normal de-
velopmental time and continues to be expressed during the
extended G1 period due to a failure to activate its own down
regulation (see above).
The molecular mechanism behind such an all-or-nothing
threshold is not clear. Positive feedback amplification has been
a popular proposal for controlling all-or-nothing cell cycle
transitions. The biological activities of mammalian and Dro-
sophila cyclin E and E2F-DP can formally be placed into a
positive feedback loop: overexpression of cyclin E activates
E2F-DP, probably due to cyclin E-cdk2 phosphorylation of
pRB, and E2F-DP activates cyclin E transcription. This type of
positive feedback loop makes an attractive model for control of
the restriction point (10, 23, 57), the time during G1 that
mammalian cells commit to S-phase entry (50). Similar types of
interactions between the S. cerevisiae Swi4/6 transcription fac-
tor and G1 cyclin genes (CLNs) can be demonstrated (43, 45).
However, during START, the yeast equivalent of the restric-
tion point, careful genetic experiments have ruled out positive
feedback amplification between CLN1 or CLN2 and the Swi4/6
transcription factor (12, 63). Similarly, in Drosophila endocy-
cling cells the genetic evidence indicates that there is no pos-
itive feedback amplification between cyclin E and dE2F-dDP
at the G1-S transition, although each can induce the activity of
the other when overexpressed (14, 16). The lack of positive
feedback appears to be the consequence of negative feedback
mechanisms involving cyclin E, as described above (16, 41, 53).
These overcome any contribution of cyclin E to positive feed-
back. Thus, because cyclin E does not make a positive contri-
bution to its own expression in our experimental context, cyclin
E provides a threshold for entry into S phase by a mechanism
that does not require positive feedback between cyclin E and
dE2F-dDP.
What then is the function of cyclin E? After formation of
prereplicative complexes during G1, and a commitment to
progress into S phase, a poorly described mechanism exists that
triggers the initiation of DNA replication. In vitro experiments
suggest that cdk activity could comprise part of the trigger
mechanism. In frog and human extracts, cyclin E-cdk2 and
cyclin A-cdk2 are required for DNA synthesis (20, 31, 35, 62).
These kinases presumably have substrates that must be phos-
phorylated in order for replication origins to fire. Moreover,
cyclin E has an essential S-phase function that is independent
of E2F-DP-mediated transcription (14, 42). Whatever the crit-
ical substrates are, our data suggest that cyclin E-cdk2 must be
part of a mechanism that in vivo has an all-or-nothing re-
sponse. Cyclin E could activate an amplifying kinase cascade,
trigger changes in protein degradation, or affect DNA unwind-
ing and initiation directly at origins of replication.
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